He ʻano hana ikaika ʻo Metformin hydrochloride me kahi hopena hoʻohaʻahaʻa i ke kō. Hoʻomaopopo pinepine ʻia ka lāʻau ma ke ʻano o ka mālama paʻakikī o ka maʻi maʻamau ʻo ka maʻi 2.
Aia nā loiloi maikaʻi e pili ana i ka hoʻohana ʻana i nā papa no ka endocrine type 1 pathology me ke kākoʻo ʻana i nā inikini insulin.
ʻO ka maʻi kūpono a me ka pinepine o Metformin no ka maʻi maʻi no ka mea maʻi maʻi i hoʻoholo ʻia e ka endocrinologist, me ka noʻonoʻo ʻana i kekahi mau mea.
ʻĀpana Pharmacological
ʻO ka Metformin kahi lāʻau lapaʻau me ka hopena hypoglycemic. Hoʻohana ikaika ka lāʻau antidiabetic Oral i ka mālamaʻana i ka pathology endocrine type 2, ʻoi aku ka nui - i ka hoʻohui pū ʻana i ka insulin. ʻO ke ʻano nui o ka hoʻolaha ʻana he haʻahaʻa o ke kō koko.
Nā hopena hopena o Metformin
ʻO ka hopena paʻakikī i ke kino me ka ʻano like ole-insulin-ʻano ʻano maʻi like ʻo ia kekahi o nā pono o kahi lāʻau kūpono. ʻAʻole paʻa ka mea ikaika i ke kōpaʻa koko, akā hoʻomaikaʻi nō hoʻi i ka metabolidity lipid. Hoʻomaʻamaʻa ka lāʻau lapaʻau i ka hana o ke pancreas (hōʻike i kahi hopena hypoglycemic peripheral), kahi emi iki o ka puhopu o ka glucose i hana pinepine ʻia.
Ma hope o ka lawe ʻana i ka Metformin, pane maikaʻi ke kino i nā mea i hoʻohui ʻia ʻo ia me nā mea e antidiabetic:
- ka emi o ka hoʻonui ʻana i ka glucose mai nā lipids a me nā protein;
- hoʻonui ka naʻau i ka insulin;
- Hoʻokuʻu lūlū ʻia nā glycogen mai nā selika o ka ate, e hoʻi ka pae i ke kō o ke koko;
- ua hoʻopau aku nā mea kani i ka glucose i ikaika nui aku;
- Hoʻonui ka hoʻomaikaʻi ʻia ʻana o ka cholesterol maikaʻi, ka pālepa o ka momona;
- ka emi iki o ka glucose mai ka ʻōpū;
- ma ka huina o ka digestive kahi i hoʻonui ʻia i ka loli o ka glucose.
ʻOi aku ma mua o 50% o nā mea maʻi me ka pale ʻana i ka insulin a ʻaʻole i lawa ka hoʻoliʻina insulin e loaʻa i kahi hopena hypoglycemic maikaʻi.
Nā hōʻailona no ka koho
ʻO ka lāʻau Metformin ka mea nui i ka mālamaʻana i nā maʻi o ka maʻi ole-insulin (type 2 pathology).
Hoʻohana ʻia ka lāʻau lapaʻau e ka metformin hydrochloride no ka maʻi endocrine type 1 e hoʻomalu ai i ka hoʻoliʻi glucose, ʻoi aku hoʻi i nā inikini insulin.
Nā hōʻailona ʻē aʻe:
- paʻakikī ka hopena o ka hoʻonāukiuki ma hope o ka pale ʻana o ka insulin;
- polycystic ovary syndrome;
- me ke kō koko kiʻekiʻe ma kahi ʻōpū ʻole;
- i nā lāʻau lapaʻau haʻuki;
- me ka hoʻohaʻahaʻa ʻana i ka hoʻohaʻahaʻa glucose.
ʻĀnō
Hāʻawi nā mea lāʻau lapaʻau i ʻelua mau ʻano o ka Metformin:
- hoonui;
- maʻamau.
Aia i nā papa pākuʻi ʻokoʻa maau - mai 500 a 1000 mg. Nui nā pūʻulu antidiabetic i hoʻohui pū i nā pakanui paʻa, akā ma nā wahi liʻiliʻi.
Koho ka endocrinologist i kahi maʻa maikaʻi loa e noʻonoʻo i ke kiʻekiʻe o ka glucose i ke koko a me ke ʻano o ka maʻi maʻi. ʻO ka koi haʻahaʻa loa i kēlā lā i kēia lā e hoʻokō i ka hopena hoʻohaʻahaʻa honu he 500 mg. Me ka pilikia nui o ka hyperglycemia, e like me ka kauka ʻana i kauka, hiki iā ʻoe ke hoʻonui i ka komo o ka metformin hydrochloride i 2 g.
ʻAno maʻi type 2
ʻO ka metformin kahi hypoglycemic nui. ʻO ka awelika nui o kēlā me kēia lā he 0.5 a 0.85 g, ka nui o ka 1 papa.
Me ka hoʻomohala ʻana o ka maʻi ʻaʻai a me ka maʻi ʻauʻau, e hoʻohana i ka lāʻau lapaʻau me ka meaʻai, maikaʻi ma hope o ka ʻai ʻana, inu me ka wai.
Me kahi hopena palupalu, i ka ʻae ʻana me ke kauka, hiki iā ʻoe ke hoʻonui i ka pākaukau i kēlā me kēia lā i 2 g.
Ka hoʻihoʻi mau nei ʻo Carbohydrate i ka maʻamau ma hope o ʻelua a ʻekolu mau pule. Me ka hoʻemi ʻana ma ke pae o ka hyperglycemia, hoʻemi iki ʻia ka nui o ka dosage. Ke ʻae ʻia nei ka helu o nā papa a me nā ʻae i kēlā me kēia lā e like me ka kuhikuhi ʻana e ka endocrinologist.
Nā nuances nui:
- me ka metabolic syndrome e kūʻai ai i ka maʻi maʻi, hiki iā ʻoe ke kiʻi i nā papa e pili ana i ka metformin hydrochloride e hoʻomaʻamaʻa i ka hana metabolism, hoʻēmi i ka triglycerides, hoʻemi i ka hyperglycemia kiʻekiʻe ma hope o ka ʻaina;
- hui pū me ka hoʻomākaukau ʻo sulfonylurea e hoʻomaikaʻi i ka hana metabolism i 60% o nā maʻi. Ke emi nei ke kiʻekiʻe o ka glycemia - hāʻule ke kumukūʻai o ke kō ma kahi o 20-40%. ʻOi ka manawa, hana ke kino i ka hana a nā lāʻau lapaʻau me ka sulfonylurea. Mālama ka hana Metformin i ka lipid metabolism mau hoʻokū a me ke kōpaʻa koko kiʻekiʻe.
ʻAno maʻi type 1
Hoʻomaopopo pinepine ʻia ka lāʻau no ka pathology type 2, akā he nui nā kauka e hoʻohui i ka hoʻonāukiuki ʻana i ka insulin me Metformin.
Hoʻonohonoho ka hopena paʻakikī i ke kūlana o ka mea maʻi.
ʻO ke hoʻonuiʻana i nā pae insulin ma hope o ka maʻi maʻi, i hui pū ʻia me ka hoʻemi ʻana i ka hoʻāʻo ʻana o ka glucose, e hōʻemi ana i ka hopena o nā hoʻonāukiuki i ka ʻano like o ka maʻi o ka insulin.
ʻO ka hopena antidiabetic therapy (injections o insulin a me metformin hydrochloride) e hōʻemi ana i ka pono no ka mālama ʻana i ka hormone ma o 20% a i ʻole. Hōʻike pinepine nā hoʻomaʻamaʻa i kahi hoʻomaikaʻi i ke kaola hoʻoliʻi.
Hiki ke hoʻohana i ka Metformin e pale ai i ka maʻi maʻi?
Ua hana i nā kauka ʻAmelika i ka hopena o ka kenekulia 20 no ka noiʻi nui ʻana e noiʻi i ka hopena o ka aihue hypoglycemic me nā hopena peripheral i haʻi ʻia.
Ua kono ʻia nā mea maʻi i ka pilikia: me ka hoʻomanawanui i ka hoʻohaʻahaʻa glucose a hōʻoia i ka prediabetes paʻa.
Nui ka poʻe i loaʻa mai i ka momona, hoʻopiʻi i ke koko kiʻekiʻe, nā pilikia naʻau, nā hōʻike i hōʻike i kahi pae koʻikoʻi o ka triglycerides a me ka "bad" cholesterol.
Ua hana ʻia nā ana ʻana a me nā hoʻokolohua ma nā kikowaena 27. Loaʻa i nā mea maʻi ʻo Metformin ʻelua mau lā i ka lā 850 g no nā makahiki ʻekolu. Ua hōʻike ʻia nā noiʻi: lāʻau lapaʻau lāʻau, hoʻohui me ka hoʻoponopono ʻana o ke ola a me ka meaʻai, hoʻemi ʻia ka make mai nā pathologies cardiovascular.
Hōʻike ka lāʻau antidiabetic i ka hana maikaʻi loa a hōʻike i ka hoʻomau ʻana o nā kuhi gula koko me kahi predisposition i ka maʻi maʻi i ka poʻe me ka maʻi nui. ʻOiai me ka hana maʻamau, ka hiki ʻana o ka hoʻomohala ʻana i ke ʻano o ka maʻi kūʻokoʻa i ka insulin i ka 30%. ʻOi nā hopena o ka lāʻau i ka wā eʻai ai, ka hoʻonui ʻana i ka hana kaʻa, a me ka hoʻohaʻahaʻa ʻana i ke kiʻekiʻe o ke kaumaha ʻoi aku ka kiʻekiʻe: i ka 58% o nā kānaka i ka hopena, ua hoʻomau ka piʻi o ka glucose.
Nā Hoʻohui
ʻAʻole e like me nā ʻano lāʻau antidiabetic ʻē aʻe, ʻo Metformin a me nā mea hoʻopalike ʻia he liʻiliʻi nā palena liʻiliʻi:
- makahiki 10 o ke keiki;
- ua hōʻeha ʻia a me nā hana ʻino;
- kahi mōʻaukala lactic acidosis;
- lactation wā;
- kalaka intake ma lalo o 1000 kcal i kēlā me kēia lā: ʻoi ke kiʻekiʻe o ka metabolabous acidosis;
- pilikia ʻole;
- nā maʻi hōʻeha ʻeha;
- nā kuʻuna ʻaila;
- hapai
- kuʻuna i hiki ke ulu ʻia nā hoʻomōhala lactic acidosis.
Nā ʻōlelo kikoʻī
I ka wā e mālama ai me Metformin, he mea nui e ʻike: ʻo ke kiʻekiʻe o ke kaohi o ka mea hana e alakaʻi i ka hypoglycemia, akā me kahi overdose, hiki i ka hoʻomohala hoʻokūkū - kūloko lactic acidosis. Pono ka poʻe maʻi a me nā hoahānau o ka mea maʻi e ʻike i nā hōʻailona o nā loli pathological e hiki koke ke kāhea aku i kahi ambulance no kāna hōʻaiʻe wikiwiki.
ʻO ke kiʻi lapaʻau me ka hoʻolālā ʻana o ka hoʻomehana lactic:- ke holo wikiwiki nei;
- nā ninia
- hypothermia;
- ninini
- ʻehaʻeha ka naʻau;
- utuka
- huʻihili ʻōwili;
- nalowale o ka ike ana.
Nā kuʻina
ʻO ka metformin hydrochloride he ʻāpana o nā lāʻau āpau. Hāʻawi nā lāʻau lapaʻau i nā lāʻau lapaʻau me nā mea ikaika ma lalo o nā inoa like ʻole i nā lāʻau lapaʻau. ʻO ka ʻokoʻa ʻole i nā mea kōkua kōkua ʻaʻole i hoʻopilikia i nā hana kumu i loko o ke kino.
ʻO nā inoa maikaʻi e pili ana i ka metformin hydrochloride:
- ʻ Formlelo.
- Hoʻolaha.
- ʻO Metospanin.
- KiKiluna.
- Siofor.
- ʻO Glyminfor.
- Novoformin.
- Vero-Metformin.
- Bagometua.
- ʻO Dianormet a me nā mea ʻē aʻe.
Hōʻikeʻike ʻo Metformin a me kona mauʻikepili i kahi hopena hypoglycemic paʻa i ka maʻi diabetes type 2.
Hōʻike pū ʻia ka hopena maikaʻi o ka ʻoihana me kahi ʻano hana like me ka maʻi o ka patology. Kuhi ʻia i kēlā me kēia lā, ʻike ʻia nā hopena maikaʻi ʻole i ka hapa liʻiliʻi o nā mea maʻi. ʻO ka uku kumukūʻai (mai 110 a 190 mau rubles, kākūmū No. 30 a me ʻĀkolu 60) he pono kūpono ʻole ia me ke ʻano lōʻihi o ka mālama ʻana.
